RGNT REGENTIS BIOMATERIALS LTD
FollowORDINARY SHARES (common), issuer CIK 1912966
Filings received so far for Q3 2026: 6 13F filers report a position in RGNT shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| Rosalind Advisors, Inc.in group Rosalind Advisors, Inc. | 701,685 | $1.27M | 0.41% | 0 | 13F-HRTimelineGroup |
| Warberg Asset Management LLC | 58,526 | $109K | 0.02% | -28,454 | 13F-HRTimeline |
| CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC | 58,924 | $107K | <0.01% | new | 13F-HRTimelineGroup |
| JANE STREET GROUP, LLCin group JANE STREET GROUP, LLC | 43,240 | $78.3K | <0.01% | -93 | 13F-HRTimelineGroup |
| Marex Group Ltdin group Marex Group Ltd | 29,371 | $53.2K | <0.01% | new | 13F-HRTimelineGroup |
| UBS Group AGin group UBS Group AG | 1,246 | $2.26K | <0.01% | +812 | 13F-HRTimelineGroup |